Characterizing the Emergence of Myeloid‐Derived Suppressor Cell Subsets in a Murine Model of Pulmonary Fibrosis
The FASEB Journal · 2025
DOI: 10.1096/fj.202500312rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Nora Vedder und 8 weiteren Autor:innen. Beteiligte Einrichtung: German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC) Philipps University Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Pulmonary Fibrosis. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftung für Pathobiochemie und Molekulare Diagnostik (Foundation for Pathobiochemistry and Molecular Diagnostics), Deutsche Forschungsgemeinschaft (DFG), Deutsche Zentrum für Lungenforschung.
Abstract (Originalsprache)
The immune system plays a major role in pulmonary fibrosis (PF), a devastating lung disease with limited treatment options. Myeloid‐derived suppressor cells (MDSCs) are immune cells with remarkable immunosuppressive functions. We hypothesized that their anti‐inflammatory activity may dampen PF by inhibiting inflammation and its transition to fibrosis. Here, we studied the emergence of both polymorphonuclear (PMN)‐ and monocytic (M)‐MDSCs in a murine model of PF. We assessed immunological, histopathological, and clinical changes at days 3, 7, 14, and 21 following bleomycin challenge. A comprehensive overview of the role of MDSCs during the acute lung injury and chronic phase of pulmonary fibrosis is provided, along with the effects of MDSCs adoptive transfer and depletion. Inflammation and fibrosis increased over a period of 21 days after bleomycin administration. In the lung, the number of PMN‐MDSCs increased, while M‐MDSCs decreased over the time following bleomycin challenge. Especially, M‐MDSCs showed enhanced suppressive activity on day 3 following bleomycin challenge. Adoptive transfer of PMN‐MDSCs attenuated inflammation and fibrosis development. However, depletion of PMN‐MDSCs did not lead to an exacerbation of PF. Our results suggest that adoptive transfer of PMN‐MDSCs can ameliorate the inflammatory responses and thus the development of fibrosis in a bleomycin‐induced pulmonary fibrosis model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC) Philipps University Marburg, Marburg, Germany.
- Preclinical Imaging Core Facility, Center for Tumor Biology and Immunology (ZTI), Philipps University Marburg, Marburg, Germany.
ORCID-Profile: Saeed Kolahian
Förderung
- Stiftung für Pathobiochemie und Molekulare Diagnostik (Foundation for Pathobiochemistry and Molecular Diagnostics)
- Deutsche Forschungsgemeinschaft (DFG)
- Deutsche Zentrum für Lungenforschung
- Deutsches Zentrum für Lungenforschung
Zitieren
APA
Vedder, N., Gercke, P., Lautenschlager, N., Brunn, T., Lange, T., Schieb, J., Vetter, C., van Geffen, C., & Kolahian, S. (2025). Characterizing the Emergence of Myeloid‐Derived Suppressor Cell Subsets in a Murine Model of Pulmonary Fibrosis. The FASEB Journal. https://doi.org/10.1096/fj.202500312rr
Vancouver
Vedder N, Gercke P, Lautenschlager N, Brunn T, Lange T, Schieb J, et al. Characterizing the Emergence of Myeloid‐Derived Suppressor Cell Subsets in a Murine Model of Pulmonary Fibrosis. The FASEB Journal. 2025. doi:10.1096/fj.202500312rr
BibTeX
@article{Vedder2025,
author = {Vedder, Nora and Gercke, Philipp and Lautenschlager, Nikoleta and Brunn, Tobias and Lange, Tim and Schieb, Jakob and Vetter, Charlotte and van Geffen, Chiel and Kolahian, Saeed},
title = {Characterizing the Emergence of Myeloid‐Derived Suppressor Cell Subsets in a Murine Model of Pulmonary Fibrosis},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500312rr}
}
EUVIMED